Literature DB >> 2161026

Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis.

S Tracy1, V Wiegand, B McManus, C Gauntt, M Pallansch, M Beck, N Chapman.   

Abstract

Enteroviruses are thought to be etiologic agents in some cases of human myocarditis and dilated cardiomyopathy. Murine models of acute coxsackievirus B3 myocarditis implicate coxsackie B viruses as possible causes of human myocarditis. Indirect evidence implicating enteroviruses as causative agents in human heart disease derives from serologic studies. More recently, direct evidence for enteroviral presence in diseased human heart tissues has been obtained by nucleic acid hybridization analyses. Although the data suggest that enteroviral infections may be associated with 18% to 50% of cases of myocarditis or dilated cardiomyopathy, or both, causality has not been established. Unanswered questions remain regarding the specific identity of the enteroviral genomes detected in the human heart and the potential for enteroviruses to persist in the heart.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161026     DOI: 10.1016/0735-1097(90)92846-t

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

1.  Detection of enteroviruses in cell cultures by using in situ transcription.

Authors:  J M Carstens; S Tracy; N M Chapman; C J Gauntt
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

2.  Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients.

Authors:  John P Breinholt; Mousumi Moulik; William J Dreyer; Susan W Denfield; Jeffrey J Kim; John L Jefferies; Joseph W Rossano; Corey M Gates; Sarah K Clunie; Karla R Bowles; Debra L Kearney; Neil E Bowles; Jeffrey A Towbin
Journal:  J Heart Lung Transplant       Date:  2010-04-24       Impact factor: 10.247

3.  eHEART: www.heartjnl.com.

Authors: 
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

Review 4.  [Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation].

Authors:  S Pankuweit; G Hufnagel; H Eckhardt; H Herrmann; S Uttecht; B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

Review 5.  [Therapy of dilated cardiomyopathies with and without inflammation].

Authors:  G Hufnagel; S Pankuweit; B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

6.  Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice.

Authors:  Carola Leipner; Katja Grün; Ilka Schneider; Brigitte Glück; Holger H Sigusch; Axel Stelzner
Journal:  Med Microbiol Immunol       Date:  2003-10-31       Impact factor: 3.402

Review 7.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

8.  Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction.

Authors:  P J Keeling; S Jeffery; A L Caforio; R Taylor; G F Bottazzo; M J Davies; W J McKenna
Journal:  Br Heart J       Date:  1992-12

9.  Detection of viral RNA in experimental coxsackievirus B3 myocarditis of mice using the polymerase chain reaction.

Authors:  I Okada; A Matsumori; B Kyu
Journal:  Int J Exp Pathol       Date:  1992-12       Impact factor: 1.925

10.  Verapamil ameliorates the clinical and pathological course of murine myocarditis.

Authors:  R Dong; P Liu; L Wee; J Butany; M J Sole
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.